Title | Type | SJR | H index | Total Docs. (2015) | Total Docs. (3years) | Total Refs. (2015) | Total Cites (3years) | Citable Docs. (3years) | Cites / Doc. (2years) | Ref. / Doc. (2015) | %Female (2015) | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
51 | Bioorganic and Medicinal Chemistry | journal | 1.030 Q1 | 187 | 759 | 2258 | 31651 | 7202 | 2247 | 3.16 | 41.70 | 36.29 | |
52 | Drug Discovery Today: Technologies | journal | 1.009 Q1 | 62 | 41 | 140 | 1545 | 421 | 125 | 2.69 | 37.68 | 31.58 | |
53 | Journal of Applied Toxicology | journal | 1.008 Q2 | 103 | 161 | 423 | 7897 | 1449 | 420 | 3.30 | 49.05 | 42.47 | |
54 | Journal of Toxicology and Environmental Health - Part A: Current Issues | journal | 0.997 Q2 | 99 | 119 | 374 | 5459 | 967 | 368 | 2.54 | 45.87 | 47.46 | |
55 | Clinical and Experimental Pharmacology and Physiology | journal | 0.978 Q2 | 115 | 161 | 416 | 7288 | 961 | 374 | 2.11 | 45.27 | 41.37 | |
56 | Mutagenesis | journal | 0.965 Q2 | 102 | 89 | 228 | 4467 | 603 | 226 | 2.54 | 50.19 | 43.90 | |
57 | Pharmacogenomics | journal | 0.965 Q2 | 100 | 178 | 635 | 9993 | 1465 | 528 | 2.29 | 56.14 | 42.10 | |
58 | Molecular Diagnosis and Therapy | journal | 0.948 Q2 | 68 | 46 | 155 | 1979 | 435 | 151 | 2.85 | 43.02 | 46.09 | |
59 | Tetrahedron | journal | 0.941 Q1 | 236 | 1084 | 3718 | 58434 | 10956 | 3704 | 2.90 | 53.91 | 32.25 | |
60 | MedChemComm | journal | 0.936 Q1 | 0 | 0 | 0 | 0 | 0 | 0 | 0.00 | 0.00 | 0.00 | |
61 | Bioorganic and Medicinal Chemistry Letters | journal | 0.923 Q1 | 166 | 1079 | 3884 | 31662 | 10488 | 3884 | 2.74 | 29.34 | 33.38 | |
62 | Expert Opinion on Pharmacotherapy | journal | 0.907 Q2 | 93 | 251 | 734 | 17110 | 2183 | 705 | 3.15 | 68.17 | 32.16 | |
63 | Toxicon | journal | 0.904 Q2 | 144 | 270 | 768 | 12473 | 2134 | 749 | 2.62 | 46.20 | 45.43 | |
64 | BioDrugs | journal | 0.894 Q2 | 79 | 35 | 146 | 2111 | 483 | 141 | 3.39 | 60.31 | 42.31 | |
65 | Alcohol and Alcoholism | journal | 0.885 Q2 | 109 | 103 | 357 | 3465 | 921 | 323 | 2.56 | 33.64 | 49.11 | |
66 | Expert Opinion on Drug Metabolism and Toxicology | journal | 0.865 Q2 | 100 | 148 | 382 | 12625 | 1188 | 379 | 3.07 | 85.30 | 36.99 | |
67 | Biomarkers in Medicine | journal | 0.859 Q2 | 56 | 126 | 321 | 6671 | 661 | 267 | 1.86 | 52.94 | 38.78 | |
68 | BMC pharmacology & toxicology | journal | 0.853 Q2 | 43 | 41 | 160 | 1456 | 393 | 154 | 2.57 | 35.51 | 35.20 | |
69 | Phytotherapy Research | journal | 0.850 Q2 | 158 | 247 | 832 | 10066 | 2555 | 828 | 3.25 | 40.75 | 39.77 | |
70 | Phytochemical Analysis | journal | 0.847 Q2 | 83 | 52 | 250 | 1484 | 683 | 248 | 2.87 | 28.54 | 40.66 | |
71 | Inhalation Toxicology | journal | 0.832 Q2 | 97 | 84 | 270 | 4386 | 719 | 258 | 2.25 | 52.21 | 36.76 | |
72 | Future Medicinal Chemistry | journal | 0.825 Q2 | 90 | 187 | 568 | 12466 | 1450 | 447 | 2.21 | 66.66 | 35.68 | |
73 | Expert Review of Clinical Pharmacology | journal | 0.817 Q1 | 60 | 58 | 249 | 4113 | 574 | 215 | 2.41 | 70.91 | 34.68 | |
74 | Chemical Biology and Drug Design | journal | 0.814 | 91 | 226 | 529 | 8727 | 1400 | 519 | 2.95 | 38.62 | 37.25 | |
75 | BMC Pharmacology | journal | 0.805 Q2 | 48 | 0 | 8 | 0 | 32 | 8 | 0.00 | 0.00 | 0.00 | |
76 | Drug Testing and Analysis | journal | 0.800 Q1 | 67 | 132 | 445 | 4070 | 1144 | 410 | 2.78 | 30.83 | 36.88 | |
77 | Food Additives and Contaminants - Part A Chemistry, Analysis, Control, Exposure and Risk Assessment | journal | 0.778 Q2 | 65 | 228 | 82 | 8373 | 155 | 82 | 1.29 | 36.72 | 46.88 | |
78 | Journal of Drug Targeting | journal | 0.761 Q1 | 107 | 88 | 270 | 5790 | 866 | 264 | 3.09 | 65.80 | 42.16 | |
79 | Therapeutic Delivery | journal | 0.760 Q1 | 63 | 116 | 377 | 7967 | 903 | 331 | 2.13 | 68.68 | 34.91 | |
80 | Journal of Antibiotics | journal | 0.750 Q2 | 92 | 136 | 392 | 3367 | 844 | 378 | 2.16 | 24.76 | 35.89 | |
81 | Mathematical Medicine and Biology | journal | 0.749 Q2 | 49 | 21 | 58 | 787 | 109 | 57 | 1.19 | 37.48 | 24.64 | |
82 | Tetrahedron Letters | journal | 0.748 Q2 | 181 | 1572 | 4970 | 61643 | 12692 | 4970 | 2.55 | 39.21 | 29.05 | |
83 | Biopharmaceutics and Drug Disposition | journal | 0.733 Q1 | 65 | 52 | 149 | 1987 | 408 | 144 | 2.66 | 38.21 | 28.36 | |
84 | Journal of Peptide Science | journal | 0.729 Q2 | 73 | 111 | 316 | 5136 | 629 | 312 | 2.03 | 46.27 | 43.30 | |
85 | Journal of Clinical Pharmacy and Therapeutics | journal | 0.708 Q2 | 81 | 124 | 339 | 3722 | 717 | 334 | 2.22 | 30.02 | 45.07 | |
86 | Chinese Medicine | journal | 0.706 Q2 | 56 | 38 | 78 | 1753 | 173 | 75 | 2.06 | 46.13 | 39.24 | |
87 | Journal of Pharmacy and Pharmacology | journal | 0.696 Q1 | 137 | 165 | 548 | 7910 | 1467 | 541 | 2.59 | 47.94 | 42.82 | |
88 | Drugs in Context | journal | 0.681 Q2 | 36 | 20 | 23 | 761 | 43 | 21 | 1.65 | 38.05 | 56.16 | |
89 | Drug Delivery | journal | 0.653 Q1 | 95 | 113 | 152 | 5241 | 370 | 152 | 2.31 | 46.38 | 40.46 | |
90 | Journal of Veterinary Pharmacology and Therapeutics | journal | 0.651 Q2 | 67 | 89 | 279 | 2706 | 390 | 270 | 1.42 | 30.40 | 42.77 | |
91 | Bioanalysis | journal | 0.641 Q1 | 70 | 278 | 949 | 10695 | 1943 | 750 | 2.04 | 38.47 | 39.40 | |
92 | Fundamental and Clinical Pharmacology | journal | 0.637 Q2 | 85 | 64 | 232 | 2798 | 485 | 232 | 2.39 | 43.72 | 48.31 | |
93 | Antiviral Chemistry and Chemotherapy | journal | 0.621 Q2 | 59 | 20 | 42 | 577 | 91 | 41 | 1.95 | 28.85 | 33.33 | |
94 | F1000Research | journal | 0.620 Q1 | 105 | 351 | 466 | 15979 | 522 | 457 | 1.15 | 45.52 | 36.55 | |
95 | Xenobiotica | journal | 0.607 Q3 | 89 | 120 | 361 | 3967 | 710 | 354 | 1.80 | 33.06 | 35.77 | |
96 | Journal of Liposome Research | journal | 0.576 Q1 | 64 | 34 | 109 | 1332 | 245 | 109 | 1.89 | 39.18 | 42.68 | |
97 | Food Additives and Contaminants: Part B Surveillance | journal | 0.566 Q3 | 41 | 48 | 153 | 1504 | 247 | 153 | 1.70 | 31.33 | 44.83 | |
98 | Toxicology Mechanisms and Methods | journal | 0.562 Q3 | 55 | 84 | 264 | 3744 | 452 | 262 | 1.74 | 44.57 | 44.50 | |
99 | Biomedical Chromatography | journal | 0.559 Q2 | 71 | 249 | 705 | 6602 | 1267 | 693 | 1.77 | 26.51 | 39.72 | |
100 | BMC Clinical Pharmacology | journal | 0.557 Q3 | 43 | 0 | 14 | 0 | 44 | 14 | 0.00 | 0.00 | 0.00 |
Follow us on @ScimagoJR
Scimago Lab, Copyright 2007-2024. Data Source: Scopus®